Cormorant Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-400,000	Closed	-$3.05M	–	95
2021 Q3	$3.05M	Sell	400,000 -100,000	-20%	-$848K	0.12%	79
2021 Q2	$4.84M	Sell	500,000 -2,250,000	-82%	-$17.9M	0.19%	82
2021 Q1	$22.7M	Sell	2,750,000 -1,750,000	-39%	-$18.5M	0.65%	44
2020 Q4	$30.7M	Sell	4,500,000 -1,500,000	-25%	-$12M	0.89%	36
2020 Q3	$66.9M	Sell	6,000,000 -500,000	-8%	-$4.58M	2.94%	9
2020 Q2	$40.8M	Buy	6,500,000 +1,500,000	+30%	+$5.74M	1.79%	24
2020 Q1	$9.2M	Buy	5,000,000 +1,000,000	+25%	+$2.88M	0.52%	50
2019 Q4	$13.5M	Buy	+4,000,000	New	+$9.54M	0.6%	47
2017 Q3	–	Sell	-1,690,800	Closed	-$3.38M	–	70
2017 Q2	$3.38M	Hold	1,690,800	–	–	0.56%	46
2017 Q1	$6.68M	Sell	1,690,800 -218,200	-11%	-$1.09M	0.97%	33
2016 Q4	$9.35M	Sell	1,909,000 -212,013	-10%	-$1.27M	1.26%	26
2016 Q3	$16.4M	Hold	2,121,013	–	–	1.81%	20
2016 Q2	$11.9M	Buy	2,121,013 +25,679	+1%	+$164K	1.68%	22
2016 Q1	$11.3M	Hold	2,095,334	–	–	1.7%	23
2015 Q4	$18.3M	Hold	2,095,334	–	–	2.18%	13
2015 Q3	$17.6M	Buy	2,095,334 +150,000	+8%	+$2.39M	2.81%	10
2015 Q2	$34.3M	Buy	1,945,334 +292,422	+18%	+$3.76M	4.56%	7
2015 Q1	$19.1M	Sell	1,652,912 -97,088	-6%	-$1.12M	2.95%	8
2014 Q4	$17.6M	Buy	1,750,000 +750,000	+75%	+$3.8M	2.73%	11
2014 Q3	$4.52M	Hold	1,000,000	–	–	0.93%	32
2014 Q2	$6.75M	Buy	1,000,000 +300,000	+43%	+$2.26M	1.81%	21
2014 Q1	$8.97M	Buy	+700,000	New	+$7.75M	2.06%	18